miércoles, 7 de mayo de 2014

Health and financial analysis reinforces NIH's decision to fund Women's Health Initiative

Health and financial analysis reinforces NIH's decision to fund Women's Health Initiative



NHLBI_Standard_Sig_Logo_RGB - New

Press Releases

An in-depth analysis of final data from one of the Women’s Health Initiative
(WHI) Postmenopausal Hormone Therapy Trials has found that the
investment in WHI resulted in a return of $140 in net economic value
for each dollar invested in the trial.
The WHI, sponsored by the National Institutes of Health’s National Heart,
Lung, and Blood Institute (NHLBI), has followed women in the study since
1993. Results of the trial of estrogen plus progestin were published in 2002.
A paper examining the national post-study long-term financial and health
outcomes of the WHI was published today in the Annals of Internal Medicine.
Related links:

No hay comentarios: